TOPICAL APPLICATION OF LOW MOLECULAR WEIGHT HEPARIN IN A RABBIT TRAUMATIC ANASTOMOSIS MODEL

By Fu K.   Izquierdo R.   Vandevender D.   Warpeha R.L.   Wolf H.   Fareed J.  

Thrombosis Research, Vol. 86, Iss. 5, 1997-06 ,pp. : 355-361

Elsevier

Access to resources Recommend Favorite

A New Therapeutic Option by Subcutaneous Recombinant Hirudin in Patients with Heparin-induced Thrombocytopenia Type II - A Pilot Study

By Huhle G.   Hoffmann U.   Hoffmann I.   Liebe V.   Harenberg J.F.   Heene D.L.  

Thrombosis Research, Vol. 99, Iss. 4, 2000-08 ,pp. : 325-334

Elsevier

Access to resources Recommend Favorite

Influence of Different Anticoagulants on Platelet Aggregation in Whole Blood; A Comparison between Citrate, Low Molecular Mass Heparin and Hirudin

By Wallen N.H.   Ladjevardi M.   Albert J.   Broijersen A.  

Thrombosis Research, Vol. 87, Iss. 1, 1997-07 ,pp. : 151-157

Elsevier

Access to resources Recommend Favorite

Comparative Study of Antithrombotic Effect of a Low Molecular Weight Heparin and Unfractionated Heparin in an ex Vivo Model of Deep Arterial Injury

By Roque M.   Rauch U.   Reis E.D.   Chesebro J.H.   Fuster V.   Badimon J.J.  

Thrombosis Research, Vol. 98, Iss. 6, 2000-06 ,pp. : 499-505

Elsevier

Access to resources Recommend Favorite

Neutralase &unknown; Reverses the Anti-coagulant but Not the Anti-thrombotic Activity of Heparin in a Rabbit Model of Venous Thrombosis - A developmental perspective

By Silver P.J.   Broughton R.   Bouthillier J.   Quinn T.A.   Wallace A.M.   Weishaar R.E.  

Thrombosis Research, Vol. 91, Iss. 3, 1998-08 ,pp. : 143-150

Elsevier

Access to resources Recommend Favorite